Medić-Milijić, N.; Jovanić, I.; Nedeljković, M.; Marković, I.; Spurnić, I.; Milovanović, Z.; Ademović, N.; Tomić, T.; Tanić, N.; Tanić, N.
Prognostic and Clinical Significance of PD-L1, EGFR and Androgen Receptor (AR) Expression in Triple-Negative Breast Cancer (TNBC) Patients. Life 2024, 14, 682.
https://doi.org/10.3390/life14060682
AMA Style
Medić-Milijić N, Jovanić I, Nedeljković M, Marković I, Spurnić I, Milovanović Z, Ademović N, Tomić T, Tanić N, Tanić N.
Prognostic and Clinical Significance of PD-L1, EGFR and Androgen Receptor (AR) Expression in Triple-Negative Breast Cancer (TNBC) Patients. Life. 2024; 14(6):682.
https://doi.org/10.3390/life14060682
Chicago/Turabian Style
Medić-Milijić, Nataša, Irena Jovanić, Milica Nedeljković, Ivan Marković, Igor Spurnić, Zorka Milovanović, Nejla Ademović, Tijana Tomić, Nasta Tanić, and Nikola Tanić.
2024. "Prognostic and Clinical Significance of PD-L1, EGFR and Androgen Receptor (AR) Expression in Triple-Negative Breast Cancer (TNBC) Patients" Life 14, no. 6: 682.
https://doi.org/10.3390/life14060682
APA Style
Medić-Milijić, N., Jovanić, I., Nedeljković, M., Marković, I., Spurnić, I., Milovanović, Z., Ademović, N., Tomić, T., Tanić, N., & Tanić, N.
(2024). Prognostic and Clinical Significance of PD-L1, EGFR and Androgen Receptor (AR) Expression in Triple-Negative Breast Cancer (TNBC) Patients. Life, 14(6), 682.
https://doi.org/10.3390/life14060682
